Sustainability in Procurement – from theory to practice

Synopsis

This presentation will cover the development of TiO2-free coating formulations in the pharmaceutical industry, driven by increasing regulatory scrutiny. Titanium dioxide (TiO2), traditionally used for its opacity and whiteness, faces regulatory challenges due to concerns for genotoxicity, including its classification as unsafe by EFSA when used as a food additive. We will compare various TiO2 alternatives, examining their ability to replicate TiO2’s functional properties, such as opacity and whiteness. The presentation will also delve into the formulation process, highlighting the trade-offs involved in choosing the best alternative for specific pharmaceutical applications.